Pelorus Lends $17 Million to DEA-Registered Cannabis Company Targeting Veterans
Pelorus Equity Group Announces US$16.975M Debt Financing with Royal Emerald Pharmaceuticals Funds Federally licensed 94,000 square foot cannabis cultivation and medical research facility Pharmaceutical grade facility to provide Federally...